Mr. Lee’s representative experience includes:
- Advised Achilles Therapeutics, a biopharmaceutical company developing personalised cancer immunotherapies, on the completion of its £52.7 million Series C.
- Advised COMPASS Pathways plc on its $146.6 million initial public offering on NASDAQ. Compass is a life sciences company dedicated to accelerating patient access to evidence based innovation in mental health.
- Advised Rockend Limited, a company aiming to create novel cell therapeutics on its seed financing and subsequent seed extension financing.
- Advised Wintermute Trading Limited, a leading global algorithmic market maker in cryptocurrency markets, on its $2.8 million Series A financing.